The Perkins Monoclonal Antibody Facility produces pure, high quality antibodies needed for medical or research purposes to researchers and commercial clients. Researchers and biotechnology companies have access to the custom-made antibodies necessary to develop new products such as diagnostic tools. Monoclonal antibodies have been used to successfully treat breast cancer, lymphoma, rheumatoid arthritis, asthma, leukaemia and in transplants to minimise the chances of organ rejection.
Our services range from production of antisera to manufacture of gram amounts of pure monoclonal antibodies. Our specialty is in the production of custom monoclonal antibodies made with our high efficiency proprietary technology. We are one of the only suppliers with a strong track record in producing MAb to novel antigens that are particularly challenging.
The facility is managed by Kathleen Davern. Kathy has many years of experience in all aspects of monoclonal antibody production and has built on these strengths to expand both national and international capabilities.
National and international researchers, clinicians and commercial groups have expressed their satisfaction with the value and efficiency of our services.
We use Perkins own super-antibody producing “Southern Cross” strain SC 073 routinely for superior monoclonal antibody production.
